All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-36949118

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	36949118	D614G	S	S	COVID-19	S L	View
2	36949118	D950N	S	S	COVID-19	S L	View
3	36949118	E156G	S	S	COVID-19	S L	View
4	36949118	L452K	S	S	COVID-19	S L	View
5	36949118	P681R	S	S	COVID-19	S L	View
6	36949118	T478K	S	S	COVID-19	S L	View
7	36949118	E484A	S	S	COVID-19	S L	View
8	36949118	G339D	S	S	COVID-19	S L	View
9	36949118	G446S	S	S	COVID-19	S L	View
10	36949118	G496S	S	S	COVID-19	S L	View
11	36949118	L452R	S	S	COVID-19	S L	View
12	36949118	N440K	S	S	COVID-19	S L	View
13	36949118	N501Y	S	S	COVID-19	S L	View
14	36949118	P681H	S	S	COVID-19	S L	View
15	36949118	Q493R	S	S	COVID-19	S L	View
16	36949118	Q498R	S	S	COVID-19	S L	View
17	36949118	S371L	S	S	COVID-19	S L	View
18	36949118	S373P	S	S	COVID-19	S L	View
19	36949118	S477N	S	S	COVID-19	S L	View
20	36949118	Y505H	S	S	COVID-19	S L	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.